Ethan V Abel
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 10, 2026
Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance.Vishnu Kumarasamy, Jianxin Wang, Edwin Yau
|Nov 19, 2025
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma.Kennedy S Humphrey, Katherine J Crawford, Bharani Muppavarapu
|Feb 20, 2025
Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma.Katherine J Crawford, Kennedy S Humphrey, Eduardo Cortes
|Jan 31, 2024
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer.Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou
|Aug 04, 2018
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.Ethan V Abel, Masashi Goto, Brian Magnuson
Pageof 1
Frequent Collaborators
4 joint publications
Erik S Knudsen
4 joint publications
Agnieszka K Witkiewicz
2 joint publications
Vishnu Kumarasamy
2 joint publications
Jianxin Wang
2 joint publications
Kennedy S Humphrey
2 joint publications
Katherine J Crawford
1 joint publications
Brian Magnuson
1 joint publications
Diane M Simeone
1 joint publications
Costakis Frangou
1 joint publications
Yin Wan
